These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31333911)

  • 21. Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis.
    Chen Y; Jin L; Jiang Z; Liu S; Feng W
    Front Oncol; 2021; 11():644426. PubMed ID: 33937050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
    Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 24. Core genes in lung adenocarcinoma identified by integrated bioinformatic analysis.
    Yang L; Yu Q; Zhu Y; Ali Mallah M; Wang W; Feng F; Zhang Q
    Int J Environ Health Res; 2023 Mar; 33(3):243-257. PubMed ID: 34961365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
    Deng JL; Xu YH; Wang G
    Front Genet; 2019; 10():695. PubMed ID: 31428132
    [No Abstract]   [Full Text] [Related]  

  • 26. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioinformatics Analysis of Microarray Datasets to Identify Prognostic Factors in Lung Adenocarcinoma.
    Jin X; Xu L; Guan Y; Zhang Z; Li H
    DNA Cell Biol; 2020 Jun; 39(6):965-974. PubMed ID: 32330391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eleven genes associated with progression and prognosis of endometrial cancer (EC) identified by comprehensive bioinformatics analysis.
    Liu J; Zhou S; Li S; Jiang Y; Wan Y; Ma X; Cheng W
    Cancer Cell Int; 2019; 19():136. PubMed ID: 31139013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma.
    Wang Z; Li X; Chen H; Han L; Ji X; Wang Q; Wei L; Miao Y; Wang J; Mao J; Zhang Z
    Med Sci Monit; 2021 May; 27():e929333. PubMed ID: 33979320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploration of estrogen receptor-associated hub genes and potential molecular mechanisms in non-smoking females with lung adenocarcinoma using integrated bioinformatics analysis.
    Wang H; Zhang Z; Xu K; Wei S; Li L; Wang L
    Oncol Lett; 2019 Nov; 18(5):4605-4612. PubMed ID: 31611968
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
    Front Oncol; 2021; 11():754290. PubMed ID: 34745988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic biomarker candidates for pulpitis revealed by bioinformatics analysis of merged microarray gene expression datasets.
    Chen M; Zeng J; Yang Y; Wu B
    BMC Oral Health; 2020 Oct; 20(1):279. PubMed ID: 33046027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of key candidate genes associated with prognosis of lung adenocarcinoma by integrated bioinformatical analysis.
    Li J; Li Y; Jin M; Huang L; Wang X
    Transl Cancer Res; 2020 Nov; 9(11):6841-6856. PubMed ID: 35117293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis.
    Cheng C; Hua J; Tan J; Qian W; Zhang L; Hou X
    Exp Ther Med; 2019 Jul; 18(1):278-288. PubMed ID: 31258663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening and Validation of Significant Genes with Poor Prognosis in Pathologic Stage-I Lung Adenocarcinoma.
    Deng Y; Chen X; Huang C; Song J; Feng S; Chen X; Zhou R
    J Oncol; 2022; 2022():3794021. PubMed ID: 35444699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.